Top news from TCT, anticoagulation guidelines, and more
This week, a breakthrough for heart failure patients with mitral regurgitation emerges, prosthesis-patient mismatch raises the risk of death following TAVR, a new study challenges anticoagulation guidelines, and a possible blessing in disguise for rivaroxaban comes from the massive COMPASS trial. Subscribe to Cardiocast wherever you get your podcasts.
Amazon Alexa
Apple Podcasts
Create your
podcast in
minutes
It is Free